Product Program year 2025 Source: CMS Open Payments

Genadur

Drug Dermatology

Open in the dashboard

General payments

$18,672

231 payments

Research payments

$0

0 payments

Through program year 2025, $18,672 in general payments and $0 in research payments were reported against Genadur (Dermatology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $7,153 110
2024 General $3,433 15
2020 General $8,087 106

Breakdown

Who paid General payments · program years 2020–2025
  1. Medimetriks Pharmaceuticals, Inc. $18,672 231 payments
Top recipients General payments · program year 2025
  1. Jason Green Dermatology · Fort Lauderdale, FL $1,050 15% · 3 payments
  2. Azita Simoni Dermatology · Thousand Oaks, CA $483 7% · 6 payments
  3. James Childs Dermatology · College Station, TX $364 5% · 4 payments
  4. Gregg Wilentz Dermatology · Weston, FL $350 5% · 1 payment
  5. Gary Becker Internal Medicine · Brooklyn, NY $350 5% · 1 payment

The top 5 of 78 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Dermatology $4,865 70% · 45 practitioners
  2. Physician Assistant $964 14% · 16 practitioners
  3. Podiatrist $374 5% · 2 practitioners
  4. Internal Medicine $350 5% · 1 practitioner
  5. Nurse Practitioner, Family Nurse Practitioner $270 4% · 2 practitioners

The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $2,100 29% · 4 recipients
  2. California $1,742 24% · 39 recipients
  3. New York $950 13% · 3 recipients
  4. New Jersey $950 13% · 3 recipients
  5. Texas $645 9% · 15 recipients

The top 5 of 10 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

231 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record